These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4629117)

  • 21. [Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy].
    Marugo M; Mortara R; Baiardi M; Giusti M; Motta A; Grimaldi GP
    Clin Ter; 1981 Mar; 96(6):579-92. PubMed ID: 7026132
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diazoxide in the therapy of leucin sensitive hypoglycemia].
    Lücking T
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):428-9. PubMed ID: 5093940
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperinsulinemic hypoglycemia: a study of four cases].
    Féliz-De Vargas Pastor J; García Jiménez I; Sánchez Miramón F; García López P; Uriel Miñana P; Baldellou Vázquez A; Rebaje Moise V
    An Esp Pediatr; 1993 Dec; 39(6):507-11. PubMed ID: 8166405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E; Mahmood B; Garibaldi L; Sperling M
    Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism.
    Thornton P; Truong L; Reynolds C; Hamby T; Nedrelow J
    Horm Res Paediatr; 2019; 91(1):25-32. PubMed ID: 30889588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
    Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
    Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Infusion of diazoxide in severe arterial hypertension].
    Caramelo Díaz C; González Medel J; Díaz Curiel M; Fernández Guerrero M; Casado S
    Rev Clin Esp; 1982 Dec; 167(5):305-8. PubMed ID: 7167659
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperinsulinism in infants and children: diagnosis and therapy.
    Stanley CA; Baker L
    Adv Pediatr; 1976; 23():315-55. PubMed ID: 795282
    [No Abstract]   [Full Text] [Related]  

  • 29. Protein binding and vascular activity of diazoxide.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1969 Nov; 281(21):1141-5. PubMed ID: 5347827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diazoxide: tolerance and complications].
    Grünfeld JP
    Therapie; 1980; 35(5):649-50. PubMed ID: 7209864
    [No Abstract]   [Full Text] [Related]  

  • 31. Pluriglandular syndrome with hyperinsulinism. Cardiomegaly as a possible complication of diazoxide therapy.
    Appleyard WJ; Lloyd J
    Proc R Soc Med; 1968 Dec; 61(12):1257-8. PubMed ID: 4387262
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased nucleated erythrocytes in an infant with congenital hyperinsulinism.
    Carter BS
    Am J Perinatol; 1994 Mar; 11(2):113-5. PubMed ID: 8198650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperinsulinism probably caused by diffuse pancreatic hyperplasia].
    Oliete García F; Herrera Andújar P; Pérez Carmona NJ; Balboa de Paz F
    An Esp Pediatr; 1980 Nov; 13(11):1017-22. PubMed ID: 7212463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia.
    Komatsu Y; Nakamura A; Takihata M; Inoue Y; Yahagi S; Tajima K; Tsuchiya H; Takano T; Yamakawa T; Yoshida M; Miyoshi H; Terauchi Y
    Endocr J; 2016; 63(3):311-4. PubMed ID: 26598136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorpromazine in the treatment of endogenous organic hyperinsulinism.
    Federspil G; Casara D; Stauffacher W
    Diabetologia; 1974 Jun; 10(3):189-91. PubMed ID: 4845719
    [No Abstract]   [Full Text] [Related]  

  • 36. [Course of a case of organic hypoglycemia due to hyperinsulinism treated by diazoxide for 7 years].
    Fossati P; Loeuille-Fayolle F; Wemeau JL; Fourlinnie JC
    Lille Med; 1978; 23(6):422-7. PubMed ID: 682854
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.
    Chen X; Feng L; Yao H; Yang L; Qin Y
    PLoS One; 2021; 16(2):e0246463. PubMed ID: 33571197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of severe diazoxide toxicity.
    Silvani P; Camporesi A; Mandelli A; Wolfler A; Salvo I
    Paediatr Anaesth; 2004 Jul; 14(7):607-9. PubMed ID: 15200661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical grand rounds from the University of Mississippi Medical Center. Management of hyperinsulinism.
    South Med J; 1971 Dec; 64(12):1505-12. PubMed ID: 4331886
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperinsulinaemic hypoglycaemia in deoxyguanosine kinase deficiency.
    Arya VB; Dhawan A; Kapoor RR
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):900-903. PubMed ID: 31465631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.